KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Acadia Pharmaceuticals (ACAD) over the last 5 years, with Sep 2025 value amounting to $0.42.

  • Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) rose 110.00% to $0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.55, marking a year-over-year increase of 98.72%. This contributed to the annual value of $1.36 for FY2024, which is 467.57% up from last year.
  • As of Q3 2025, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $0.42, which was up 162.50% from $0.16 recorded in Q2 2025.
  • Acadia Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.86 during Q4 2024, with a 5-year trough of -$0.70 in Q1 2022.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $0.16 (2025), whereas its average is $0.15.
  • Per our database at Business Quant, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) crashed by 135.29% in 2023 and then soared by 1,900.00% in 2024.
  • Over the past 5 years, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.27 in 2021, then grew by 3.70% to -$0.26 in 2022, then soared by 207.69% to $0.28 in 2023, then surged by 207.14% to $0.86 in 2024, then surged by 110.00% to $0.42 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.42 in Q3 2025, compared to $0.16 in Q2 2025 and $0.11 in Q1 2025.